M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Novavax concludes public offering of 28.75m shares of its common stock, including exercise of underwriters' option
Biopharmaceutical company Novavax (NasdaqGS:NVAX) disclosed on Wednesday that it has completed a public offering of 28,750,000 shares of its common stock.
This public offering included 3,750,000 shares pursuant to the underwriters' option to purchase additional shares.
In the public...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives